The Hackensack, N.J., center includes 14 divisions providing care for a wide spectrum of cancer types.
Dr. McCloskey previously was interim chief of the leukemia division. He is director of the program for myeloproliferative neoplasms at the cancer center and he will continue in that role.
Before joining John Theurer, he was the chief fellow in the department of hematology and oncology at Georgetown University Hospital in Washington, D.C.
More articles on oncology:
$10M gift establishes immunotherapy center at UH Seidman Cancer Center
Radiation oncology association pushes back on CMS payment model, calls for delay
17 US cancer centers join to survey pandemic’s effects on cancer prevention, care
